Literature DB >> 32142683

Formation of Human Neuroblastoma in Mouse-Human Neural Crest Chimeras.

Malkiel A Cohen1, Shupei Zhang1, Satyaki Sengupta2, Haiting Ma1, George W Bell1, Brendan Horton3, Bandana Sharma2, Rani E George4, Stefani Spranger5, Rudolf Jaenisch6.   

Abstract

Neuroblastoma (NB), derived from the neural crest (NC), is the most common pediatric extracranial solid tumor. Here, we establish a platform that allows the study of human NBs in mouse-human NC chimeras. Chimeric mice were produced by injecting human NC cells carrying NB relevant oncogenes in utero into gastrulating mouse embryos. The mice developed tumors composed of a heterogenous cell population that resembled that seen in primary NBs of patients but were significantly different from homogeneous tumors formed in xenotransplantation models. The human tumors emerged in immunocompetent hosts and were extensively infiltrated by mouse cytotoxic T cells, reflecting a vigorous host anti-tumor immune response. However, the tumors blunted the immune response by inducing infiltration of regulatory T cells and expression of immune-suppressive molecules similar to escape mechanisms seen in human cancer patients. Thus, this experimental platform allows the study of human tumor initiation, progression, manifestation, and tumor-immune-system interactions in an animal model system.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  cancer model; immune evasion; interspecies chimeras; neural crest; neuroblastoma; pluripotent stem cells

Mesh:

Year:  2020        PMID: 32142683      PMCID: PMC7663823          DOI: 10.1016/j.stem.2020.02.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  64 in total

1.  Derivation of novel human ground state naive pluripotent stem cells.

Authors:  Ohad Gafni; Leehee Weinberger; Abed AlFatah Mansour; Yair S Manor; Elad Chomsky; Dalit Ben-Yosef; Yael Kalma; Sergey Viukov; Itay Maza; Asaf Zviran; Yoach Rais; Zohar Shipony; Zohar Mukamel; Vladislav Krupalnik; Mirie Zerbib; Shay Geula; Inbal Caspi; Dan Schneir; Tamar Shwartz; Shlomit Gilad; Daniela Amann-Zalcenstein; Sima Benjamin; Ido Amit; Amos Tanay; Rada Massarwa; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

Review 2.  Mechanisms of neuroblastoma regression.

Authors:  Garrett M Brodeur; Rochelle Bagatell
Journal:  Nat Rev Clin Oncol       Date:  2014-10-21       Impact factor: 66.675

Review 3.  Specification of neural crest cell formation and migration in mouse embryos.

Authors:  Paul A Trainor
Journal:  Semin Cell Dev Biol       Date:  2005-07-25       Impact factor: 7.727

4.  Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells.

Authors:  Toshihiro Kobayashi; Tomoyuki Yamaguchi; Sanae Hamanaka; Megumi Kato-Itoh; Yuji Yamazaki; Makoto Ibata; Hideyuki Sato; Youn-Su Lee; Jo-Ichi Usui; A S Knisely; Masumi Hirabayashi; Hiromitsu Nakauchi
Journal:  Cell       Date:  2010-09-03       Impact factor: 41.582

Review 5.  Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment.

Authors:  Stefani Spranger
Journal:  Int Immunol       Date:  2016-03-17       Impact factor: 4.823

Review 6.  Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Authors:  Nai-Kong V Cheung; Michael A Dyer
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

7.  Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.

Authors:  Stefani Spranger; Robbert M Spaapen; Yuanyuan Zha; Jason Williams; Yuru Meng; Thanh T Ha; Thomas F Gajewski
Journal:  Sci Transl Med       Date:  2013-08-28       Impact factor: 17.956

8.  Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.

Authors:  Wenqian Zhang; Ying Yu; Falk Hertwig; Jean Thierry-Mieg; Wenwei Zhang; Danielle Thierry-Mieg; Jian Wang; Cesare Furlanello; Viswanath Devanarayan; Jie Cheng; Youping Deng; Barbara Hero; Huixiao Hong; Meiwen Jia; Li Li; Simon M Lin; Yuri Nikolsky; André Oberthuer; Tao Qing; Zhenqiang Su; Ruth Volland; Charles Wang; May D Wang; Junmei Ai; Davide Albanese; Shahab Asgharzadeh; Smadar Avigad; Wenjun Bao; Marina Bessarabova; Murray H Brilliant; Benedikt Brors; Marco Chierici; Tzu-Ming Chu; Jibin Zhang; Richard G Grundy; Min Max He; Scott Hebbring; Howard L Kaufman; Samir Lababidi; Lee J Lancashire; Yan Li; Xin X Lu; Heng Luo; Xiwen Ma; Baitang Ning; Rosa Noguera; Martin Peifer; John H Phan; Frederik Roels; Carolina Rosswog; Susan Shao; Jie Shen; Jessica Theissen; Gian Paolo Tonini; Jo Vandesompele; Po-Yen Wu; Wenzhong Xiao; Joshua Xu; Weihong Xu; Jiekun Xuan; Yong Yang; Zhan Ye; Zirui Dong; Ke K Zhang; Ye Yin; Chen Zhao; Yuanting Zheng; Russell D Wolfinger; Tieliu Shi; Linda H Malkas; Frank Berthold; Jun Wang; Weida Tong; Leming Shi; Zhiyu Peng; Matthias Fischer
Journal:  Genome Biol       Date:  2015-06-25       Impact factor: 13.583

9.  Comprehensive cytogenomic profile of the in vitro neuronal model SH-SY5Y.

Authors:  Mohammed Yusuf; Kay Leung; Keith J Morris; Emanuela V Volpi
Journal:  Neurogenetics       Date:  2012-12-09       Impact factor: 2.660

10.  MYCN Amplification Is Associated with Repressed Cellular Immunity in Neuroblastoma: An In Silico Immunological Analysis of TARGET Database.

Authors:  Peng Zhang; Xiaofang Wu; Moushumi Basu; Chen Dong; Pan Zheng; Yang Liu; Anthony David Sandler
Journal:  Front Immunol       Date:  2017-11-03       Impact factor: 7.561

View more
  7 in total

Review 1.  Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.

Authors:  Kelsie L Becklin; Garrett M Draper; Rebecca A Madden; Mitchell G Kluesner; Tomoyuki Koga; Miller Huang; William A Weiss; Logan G Spector; David A Largaespada; Branden S Moriarity; Beau R Webber
Journal:  CRISPR J       Date:  2022-08

2.  RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.

Authors:  Carolina Nunes; Lisa Depestel; Liselot Mus; Kaylee M Keller; Louis Delhaye; Amber Louwagie; Muhammad Rishfi; Alex Whale; Neesha Kara; Simon R Andrews; Filemon Dela Cruz; Daoqi You; Armaan Siddiquee; Camila Takeno Cologna; Sam De Craemer; Emmy Dolman; Christoph Bartenhagen; Fanny De Vloed; Ellen Sanders; Aline Eggermont; Sarah-Lee Bekaert; Wouter Van Loocke; Jan Willem Bek; Givani Dewyn; Siebe Loontiens; Gert Van Isterdael; Bieke Decaesteker; Laurentijn Tilleman; Filip Van Nieuwerburgh; Vanessa Vermeirssen; Christophe Van Neste; Bart Ghesquiere; Steven Goossens; Sven Eyckerman; Katleen De Preter; Matthias Fischer; Jon Houseley; Jan Molenaar; Bram De Wilde; Stephen S Roberts; Kaat Durinck; Frank Speleman
Journal:  Sci Adv       Date:  2022-07-13       Impact factor: 14.957

Review 3.  In vitro Modeling of Embryonal Tumors.

Authors:  Lars Custers; Irene Paassen; Jarno Drost
Journal:  Front Cell Dev Biol       Date:  2021-02-26

Review 4.  Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.

Authors:  Chen Xue; Ganglei Li; Juan Lu; Lanjuan Li
Journal:  Signal Transduct Target Ther       Date:  2021-11-24

5.  Streamlining Culture Conditions for the Neuroblastoma Cell Line SH-SY5Y: A Prerequisite for Functional Studies.

Authors:  Sebastian Feles; Christian Overath; Sina Reichardt; Sebastian Diegeler; Claudia Schmitz; Jessica Kronenberg; Christa Baumstark-Khan; Ruth Hemmersbach; Christine E Hellweg; Christian Liemersdorf
Journal:  Methods Protoc       Date:  2022-07-12

Review 6.  Interspecies Chimeric Barriers for Generating Exogenic Organs and Cells for Transplantation.

Authors:  Phoebe Strell; Anala Shetty; Clifford J Steer; Walter C Low
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

Review 7.  From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma.

Authors:  Bieke Decaesteker; Kaat Durinck; Nadine Van Roy; Bram De Wilde; Christophe Van Neste; Stéphane Van Haver; Stephen Roberts; Katleen De Preter; Vanessa Vermeirssen; Frank Speleman
Journal:  J Pers Med       Date:  2021-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.